Classification and research status of tumor vaccines

Jiaqi Yang

DOI: https://doi.org/10.54097/f6jvyq34

2024-07-11

Abstract:As an emerging biological therapy, the classification and research status of tumor vaccines are of great significance for cancer prevention and treatment. This article aims to explore the classification of tumor vaccines and their current research progress. There are two main categories of tumor vaccines: preventive tumor vaccines and therapeutic tumor vaccines. Preventive tumor vaccines aim to prevent the occurrence of tumors by stimulating the body's immune system, while therapeutic tumor vaccines aim to use the immune system to eliminate existing tumor cells. In recent years, significant progress has been made in the research of tumor vaccines. Preventive vaccines such as HPV vaccines have shown significant effects in preventing cervical cancer. In terms of therapeutic vaccines, although still facing many challenges, multiple clinical trials have confirmed that they can enhance the immune system's ability to attack tumor cells, thereby prolonging survival and improving quality of life. Especially tumor vaccines based on mRNA technology are considered a highly promising therapeutic approach due to their unique advantages in activating specific immune responses. Overall, the field of tumor vaccines is still in a rapid development stage, and future research will focus more on their safety, effectiveness, and broad spectrum. With a deeper understanding of tumor immunology and immune escape mechanisms, tumor vaccines are expected to become an important component of cancer treatment.